Lapatinib versus trastuzumab in combination with neoadjuvant anthracycline-taxane-based chemotherapy (GeparQuinto, GBG 44): a randomised phase 3 trial - Untch, M; Loibl, S; Bischoff, J (Lancet Oncol, 2012)
et al.